A major breakthrough in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This essential tumor inhibitor protein is frequently disabled in many types of cancer, leading uncontrolled cell https://allbookmarking.com/story22089543/mini-antibodies-restore-p53-a-new-pathway-for-tumor-therapy